Skandinaviska Enskilda Banken (SEB)’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $456K | Buy |
+50,000
| New | +$456K | ﹤0.01% | 712 |
|
|
2021
Q4 | – | Sell |
-12,608
| Closed | -$559K | – | 1057 |
|
|
2021
Q3 | $559K | Sell |
12,608
-67,100
| -84% | -$2.98M | ﹤0.01% | 858 |
|
|
2021
Q2 | $4.53M | Buy |
79,708
+18,700
| +31% | +$1.06M | 0.03% | 441 |
|
|
2021
Q1 | $4.57M | Buy |
61,008
+58,908
| +2,805% | +$4.41M | 0.03% | 416 |
|
|
2020
Q4 | $182K | Buy |
+2,100
| New | +$182K | ﹤0.01% | 1009 |
|
|
2020
Q3 | – | Sell |
-6,600
| Closed | -$274K | – | 1106 |
|
|
2020
Q2 | $274K | Buy |
+6,600
| New | +$274K | ﹤0.01% | 882 |
|